Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work
Day 2 of the annual meeting of The Association for Research in Vision and Ophthalmology (ARVO 2025) in Salt Lake…
FDA Grants RMAT Designation to Atsena Therapeutics’ Gene Therapy for X-linked Retinoschisis
The designation aims to expedite development of ATSN-201 for X-linked retinoschisis, a rare inherited retinal disease with no approved treatment.The…
popular posts
